Ramiza Ramza Ramli, Shifa Zulkifli, Baharudin Abdullah, Sakinah Mohamad, Norasnieda Md Shukri
Department of Otorhinolaryngology, Head and Neck, School of Medical Sciences, Universiti Sains Malaysia, Kelantan, Malaysia.
Malays J Med Sci. 2022 Apr;29(2):126-137. doi: 10.21315/mjms2022.29.2.12. Epub 2022 Apr 21.
Chronic rhinosinusitis (CRS) affects 14% of the general population. The Sino-Nasal Outcome Test 22 (SNOT-22) is a reliable instrument assessing the impact of CRS. This study aimed to examine the reliability and construct validity of the translated Bahasa Malaysia version of SNOT-22.
This cross-sectional study was conducted in the Otorhinolaryngology clinic in Universiti Sains Malaysia (USM). Seventy CRS respondents and 39 healthy participants were included. The Bahasa Malaysia translated SNOT-22 (bmSNOT-22) was produced using rigorous forward and backward translation. Statistical analyses used included feasibility, Cronbach's alpha, intraclass correlation coefficient, Pearson's correlation coefficient and factor analysis.
The feasibility was 97.2% in the initial test and 100% in the retest. The Cronbach's alpha was 0.89 in the initial test. The average intraclass correlation coefficient (ICC) was 0.90, indicating good test-retest reliability. The bmSNOT-22 discriminated between the control group and patients ( = 15.33; < 0.001).
The bmSNOT-22 is reliable, and validity established therefore recommended for Malaysia's clinicians and researchers as a measurement tool for the outcome in sino-nasal disorders such as rhinosinusitis and nasal polyps.
慢性鼻-鼻窦炎（CRS）影响着14%的普通人群。鼻窦结局测试22项问卷（SNOT-22）是评估CRS影响的可靠工具。本研究旨在检验马来语版SNOT-22翻译版的信度和结构效度。
本横断面研究在马来西亚理科大学（USM）的耳鼻喉科诊所进行。纳入了70名CRS受试者和39名健康参与者。马来语翻译版SNOT-22（bmSNOT-22）采用严格的正向和反向翻译制作。所使用的统计分析包括可行性、克朗巴哈系数、组内相关系数、皮尔逊相关系数和因子分析。
初始测试的可行性为97.2%，复测的可行性为100%。初始测试的克朗巴哈系数为0.89。平均组内相关系数（ICC）为0.90，表明具有良好的重测信度。bmSNOT-22能够区分对照组和患者（ = 15.33； < 0.001）。
bmSNOT-22是可靠的，已确立效度，因此推荐马来西亚的临床医生和研究人员将其作为鼻窦炎和鼻息肉等鼻窦疾病结局的测量工具。
